Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.
about
Receptor for advanced glycation end products and its involvement in inflammatory diseasesTobacco smoke is a source of toxic reactive glycation productsHow hyperglycemia promotes atherosclerosis: molecular mechanisms.Role of vascular smooth muscle cell in the inflammation of atherosclerosisAlbumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cellsIdentification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complexTwo novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteinsThe oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin.Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasisDiabetes and periodontal diseases.Influence of periodontal infections on systemic health.Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.Diabetes mellitus and coronary heart disease--from prevention to intervention: Part I.Therapeutic potential of endothelin receptor antagonists in diabetes.Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy.Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathyHuman and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy.Endothelial dysfunction in children with type 1 diabetes mellitus.Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.Haemodynamics in microvascular complications in type 1 diabetes.Endothelins in chronic diabetic complications.Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteinsAssociation between diabetes complications and leukocyte counts in Iranian patientsAdvanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus.Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.Pathophysiology and Medical Treatment of Carotid Artery Stenosis.Oxidative stress and stress signaling: menace of diabetic cardiomyopathy.Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human diseaseLipid advanced glycosylation: pathway for lipid oxidation in vivoInsulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats.Advanced glycation endproducts promote adhesion molecule (VCAM-1, ICAM-1) expression and atheroma formation in normal rabbits.Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEsThe pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy.Albumin resuscitation protects against traumatic/hemorrhagic shock-induced lung apoptosis in rats.Cellular signaling and potential new treatment targets in diabetic retinopathy.
P2860
Q21285070-B6368359-1CC2-4124-8FE2-2976FFF404F2Q24623337-126FD67E-4250-481E-9498-08745DAD7BEDQ24795988-3214B2A7-8321-4993-A759-356FF5592939Q26823875-DC644F01-2B5B-4981-9B4F-AE33A55C4D65Q28362386-BEE5FAB4-7B0D-4428-801F-2B3CE77082A5Q28577438-0173E843-99D7-4F6C-822D-27A10A555F68Q28645665-40BD1052-A3BF-46C7-AA82-BD47E65BF11BQ30328108-7C25A2F2-BB5F-4C67-9EC0-71CF240D42B9Q32085442-4D99842C-1498-4900-8351-3232127A698DQ33728622-389CA250-360D-4530-8CAA-A00B840B9376Q33768655-7E878559-A71B-4DA3-AC05-C7EFA602EDC9Q33793187-516631A6-3342-4AE9-9C12-4F3DA5B29A9CQ33901974-855E6E95-A418-4544-A025-596DD30A6B33Q33983641-827C3F2E-19F4-44E2-B088-7F2973A16B5FQ34090982-B6C2D419-C906-40DE-A097-1154A50D57CEQ34103169-7F70DB40-198D-4663-B108-1DA0DF94B259Q34388076-16508AF1-8226-441F-97F9-7FAE17241866Q34504995-F4B4643D-B10E-410D-870B-BD49EB97EAFFQ34636106-2F3267D1-86E5-4D4F-A8EF-CCBF8D198DB4Q34728855-AAA59672-9B81-477C-AAD6-925B3BF9C2A0Q34804249-E8E59E8C-E092-48A6-9265-35A633FD2A17Q35168430-B5207C6B-A7EA-449A-910D-CFE575DE7A3DQ35605061-498FEA75-ED0F-47B9-B5EA-FEC852B2DD13Q35661794-29A02E4D-433F-4E6C-98CF-9E4DB101B3CEQ35748423-18B9EDB9-4F97-4116-A53C-9055C8247E42Q35753179-367D9C8E-FEAD-4404-A78C-B50CAADDBB28Q35764706-B8C03B72-F457-4FD3-8CA9-9FD0BE150DCCQ35788419-582A3313-ADD2-4B38-8645-4577DDDB9587Q35822678-1BB997DD-B7F7-41C1-9A4E-FF084BDB54FBQ35833696-1F888162-47BA-444E-98EB-4DA0324D370CQ36065338-A1BD4A39-82C8-4F30-8C8B-40E0041FD005Q36204491-79ECF8B0-023F-418C-A303-D371D9C15BD0Q36234407-FD15B921-CB3A-477C-886A-69F8E40968FDQ36412583-0D711F86-8D21-4E8C-B2F7-D8FD7B69697CQ36431776-4DFAA037-93DA-4100-BF0A-C07AEDC303ECQ36437599-538EB74E-D9C8-4D17-93B4-E761BE23B679Q36437790-D158D946-44FA-4E44-94BE-F06EF8843792Q36904452-07CD3F40-C1D7-459E-97FB-134C8F4E466AQ36965840-EAE9E379-7051-4FF5-B12A-812FE28C39AAQ37089750-B77FBFD0-EBD1-4E5E-A41A-E9B0B0219909
P2860
Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Endothelial receptor-mediated ...... surface coagulant properties.
@ast
Endothelial receptor-mediated ...... surface coagulant properties.
@en
type
label
Endothelial receptor-mediated ...... surface coagulant properties.
@ast
Endothelial receptor-mediated ...... surface coagulant properties.
@en
prefLabel
Endothelial receptor-mediated ...... surface coagulant properties.
@ast
Endothelial receptor-mediated ...... surface coagulant properties.
@en
P2093
P2860
P356
P1476
Endothelial receptor-mediated ...... surface coagulant properties.
@en
P2093
P2860
P304
P356
10.1084/JEM.170.4.1387
P407
P577
1989-10-01T00:00:00Z